WallStreetZenWallStreetZen

NASDAQ: TRVI
Trevi Therapeutics Inc Stock Ownership - Who owns Trevi Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Trevi Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Christopher GallettaController and Principal Accounting Officer2025-12-024,225$0.51
$2.16kBuy
Ali Behbahani10% Owner2025-04-171,851,852$1.37
$2.54MBuy
Carmen Chang10% Owner2025-04-171,851,852$1.37
$2.54MBuy
Anthony A. Florence Jr.10% Owner2025-04-171,851,852$1.37
$2.54MBuy
Forest Baskett10% Owner2025-04-171,851,852$1.37
$2.54MBuy
Mohamad Makhzoumi10% Owner2025-04-171,851,852$1.37
$2.54MBuy
New Enterprise Associates 16 LP10% Owner2025-04-171,851,852$1.37
$2.54MBuy
Scott D. Sandell10% Owner2025-04-171,851,852$1.37
$2.54MBuy
Paul Edward Walker10% Owner2025-04-171,851,852$1.37
$2.54MBuy
Thomas SciasciaChief Scientific Officer2025-03-252,631$6.60
$17.36kSell

1 of 2

TRVI insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TRVI insiders and whales buy or sell their stock.

TRVI Shareholders

What type of owners hold Trevi Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Forest Baskett17.70%22,694,708$249.87MInsider
Peter W. Sonsini13.50%17,308,374$190.57MInsider
Mohamad Makhzoumi11.05%14,171,176$156.02MInsider
Paul Edward Walker11.05%14,171,176$156.02MInsider
Anthony A. Florence Jr.11.05%14,171,176$156.02MInsider
Carmen Chang11.05%14,171,176$156.02MInsider
Ali Behbahani11.05%14,171,176$156.02MInsider
Scott D. Sandell11.05%14,171,176$156.02MInsider
Nea Management Company LLC10.31%13,222,228$145.58MInstitution
New Enterprise Associates 16 LP9.57%12,273,280$135.13MInsider

1 of 3

TRVI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TRVI43.05%56.95%Net Buying
ARDX42.21%57.79%Net BuyingNet Buying
CAPR41.32%58.68%Net BuyingNet Buying
BHVN78.77%15.74%Net BuyingNet Selling
PVLA61.11%38.89%Net BuyingNet Buying
View Top Biotech Stocks

Trevi Therapeutics Stock Ownership FAQ

Who owns Trevi Therapeutics?

Trevi Therapeutics (NASDAQ: TRVI) is owned by 101.62% institutional shareholders, 134.41% Trevi Therapeutics insiders, and 0.00% retail investors. Forest Baskett is the largest individual Trevi Therapeutics shareholder, owning 22.69M shares representing 17.70% of the company. Forest Baskett's Trevi Therapeutics shares are currently valued at $249.87M.

If you're new to stock investing, here's how to buy Trevi Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.